Last reviewed · How we verify
BIIB022 With Paclitaxel and Carboplatin — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
BIIB022 With Paclitaxel and Carboplatin (BIIB022 With Paclitaxel and Carboplatin) — Biogen.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| BIIB022 With Paclitaxel and Carboplatin TARGET | BIIB022 With Paclitaxel and Carboplatin | Biogen | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- BIIB022 With Paclitaxel and Carboplatin CI watch — RSS
- BIIB022 With Paclitaxel and Carboplatin CI watch — Atom
- BIIB022 With Paclitaxel and Carboplatin CI watch — JSON
- BIIB022 With Paclitaxel and Carboplatin alone — RSS
Cite this brief
Drug Landscape (2026). BIIB022 With Paclitaxel and Carboplatin — Competitive Intelligence Brief. https://druglandscape.com/ci/biib022-with-paclitaxel-and-carboplatin. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab